BUSINESS● LOWSep 21 · Sep 21, 2026, 5:06 PM
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
CNBC · global
Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS1h agoElections in Brazil: Lula's triumph anticipates a more limited business and trade climate for ArgentinaClarínBUSINESS1h agoBrad Klontz, doctor in psychology and financial planner: "Most people don't even realize that their mental patterns about money influence their decisions"Clarín